A multicenter randomized controlled study of temozolomide in 97 patients with malignant brain glioma

National Medical Journal of China

Volumn 89, Issue 29, 2009, Pages 2059-2062

  Qian, Zheng Zi ^a   Wang, Hua Qing ^a   Liu, Xian Ming ^a   Yang, Shu Yuan ^a   Fu, Zhen ^a   Chang, Yi ^a   Liu, Xiu Ying ^a   Yu, Hao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Brain neoplasms; Glioma; Temozolomide

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; DACARBAZINE; DOUBLE-BLIND METHOD; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84871313984     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.29.012     Document Type: Article

References (8)

1. Randes AA, Ertnani M, Basso U, et al. Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: phase II study. Ann Oncol, 2001, 12: 255-257.
2. Yung WK, Albright RE, Olson J, et al. A phase II study of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer, 2000, 83: 588-593.
3. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trails. Lancet, 2002, 359: 1011-1018.
4. Chang SM, Theodosopoulos P, Lamborn K, et al. Temozolomide in the treatment of recurrent malignant glioma. Cancer, 2004, 100: 605-611.
5. 2006, 22: 204-207.
6. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005, 352: 987-996.
7. Brada M, Hoang-Xuan K, Rampling R, et al. Multicenter phase II trial of temozolomide in patients with glioblastoma multiform at first replase. Ann Oncol, 2001, 12: 259-266.
8. Chinot OL, Barrie M, Frauger E, et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer, 2004, 100: 2208-2214.